⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL8569534 | 0.96 | — | — | |
| Formic Acid SCHEMBL11861575 | 0.93 | CA1 (0.43) | — | |
| Formic Acid SCHEMBL11861556 | 0.72 | CA1 (0.31) | — | |
| Formic Acid SCHEMBL1331809 | 0.71 | — | — | |
| Formic Acid SCHEMBL6684167 | 0.71 | ALDH1A1 (0.38) | — | |
| Formic Acid SCHEMBL15260417 | 0.71 | ALDH1A1 (0.38) | — | |
| Formic Acid SCHEMBL181555 | 0.71 | — | — | |
| SCHEMBL166 | 0.71 | — | — | |
| Formic Acid SCHEMBL6682610 | 0.71 | ALDH1A1 (0.38) | — | |
| Formic Acid SCHEMBL11248324 | 0.71 | ALDH1A1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 562 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140099695-A1 | CELL-ADHERING LIGHT-CONTROLLABLE SUBSTRATE | HITACHI HIGH-TECHNOLOGIES CORPORATION (JP) | 2014-04-10 | — | — | US | claimed |
| EP-2698426-A1 | CELL-ADHERING LIGHT-CONTROLLABLE SUBSTRATE | The Toho University (JP) | 2014-02-19 | — | — | EP | claimed |
| US-8153365-B2 | Oligonucleotide analogues | EXIQON A/S (DK) | 2012-04-10 | — | — | US | claimed |
| US-20110245327-A1 | Oligonucleotide Analogues | EXIQON A/S (DK) | 2011-10-06 | — | — | US | claimed |
| US-20090264618-A1 | Compounds With a Branched Linker | ANDRES HERBERT | 2009-10-22 | — | — | US | claimed |
| US-7572582-B2 | Oligonucleotide analogues | EXIQON A/S (DK) | 2009-08-11 | — | — | US | claimed |
| EP-1390378-B1 | PHARMACEUTICALLY ACTIVE URIDINE ESTERS | TROMMSDORFF ARZNEIMITTEL (DE) | 2009-06-17 | — | — | EP | claimed |
| EP-1327146-B1 | COMPOUNDS WITH A BRANCHED LINKER | ROCHE DIAGNOSTICS GMBH (DE) | 2005-09-14 | — | — | EP | claimed |
| US-6830886-B1 | For solid phase synthesis; genetic engineering | MEMOREC MEDICAL MOLECULAR RESEARCH COLOGNE STOFFEL GMBH (DE) | 2004-12-14 | — | — | US | claimed |
| JP-2004531543-A | — | — | 2004-10-14 | — | — | JP | claimed |
| EP-1390378-A1 | PHARMACEUTICALLY ACTIVE URIDINE ESTERS | Trommsdorff GmbH & Co. KG Arzneimittel (DE) | 2004-02-25 | — | — | EP | claimed |
| EP-1327146-A2 | COMPOUNDS WITH A BRANCHED LINKER | Roche Diagnostics GmbH (DE) | 2003-07-16 | — | — | EP | claimed |
| WO-2002088159-A1 | PHARMACEUTICALLY ACTIVE URIDINE ESTERS | TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2002-11-07 | — | — | WO | claimed |
| WO-2002027315-A2 | COMPOUNDS WITH A BRANCHED LINKER | ROCHE DIAGNOSTICS GMBH (DE) | 2002-04-04 | — | — | WO | claimed |
| US-5914370-A | STYRENIC POLYMER HAVING SYNDIOTACTIC CONFIGURATION MODIFIED WITH AN UNSATURATED COMPOUND HAVING A POLAR GROUP, OPTIONALLY MIXED WITH AN UNMODIFIED SYNDIOTACTIC POLYSTYRENE; LONG TERM HEAT STABILITY, IMPACT STRENGTH, FILLER COMPATIBILITY | IDEMITSU KOSAN CO., LTD. (JP) | 1999-06-22 | — | — | US | claimed |
| US-5684189-A | HYDROLYZING AN AZIDE TO FORM AN INTERMEDIATE AZIDE, EXTRACTING THE INTERMEDIATE AZIDE INTO AN AQUEOUS BASE AND REDUCING THE AZIDE TO AN AMINE | NORTHWESTERN UNIVERSITY (US) | 1997-11-04 | — | — | US | claimed |
| US-5272066-A | Synthetic method for enhancing glycoprotein stability | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1993-12-21 | — | — | US | claimed |
| EP-0110814-B1 | BETA-CARBOLINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-12-13 | — | — | EP | claimed |
| EP-0240352-A2 | 5-Fluorouracil derivatives and processes for producing thereof | Chisso Corporation (JP) | 1987-10-07 | — | — | EP | claimed |
| EP-0039861-B1 | PROCESS FOR THE DEGRADATION OF THE 20-CARBOXY GROUP OF DELTA 1,4-BNC(BIS-NOR-CHOLANIC ACID) AND OF RELATED STEROID DERIVATIVES, AS WELL AS SOME NITROGEN-CONTAINING STEROIDS WITH 21 CARBONS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1984-08-15 | — | — | EP | claimed |